Evidence map›Paper›PMID 30026922›Full record

ArticleF1000Research2018

A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment.

Victoria McCreanor, Nicholas Graves, Adrian G Barnett, Will Parsonage, Gregory Merlo

Abstract read
In one paragraph

Article in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. The optimal diagnostic strategies for patient with coronary artery diseases and stable chest pain syndrome: a cost-effectiveness analysis.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Victoria McCreanorInstitute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, 4059, Australia.ORCID https://orcid.org/0000-0002-0589-8521
Nicholas GravesInstitute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, 4059, Australia.ORCID https://orcid.org/0000-0002-5559-3267
Adrian G BarnettInstitute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, 4059, Australia.ORCID https://orcid.org/0000-0001-6339-0374
Will ParsonageInstitute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, 4059, Australia.ORCID https://orcid.org/0000-0002-0223-5378
Gregory MerloInstitute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, 4059, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronary artery diseasecost-effectiveness analysiseconomic analysishealth policyhealth services researchreview

Identifiers

PMID30026922
PMCPMC6039943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.